To the Editor—Since SARS-CoV-2 began spreading in late 2019, a total of 379 million cases
and 5.7 million deaths have been reported so far, with the case-fatality rate of COVID-19 …

To the Editor—Early reports of persisting symptoms following COVID-19 signaled a
debilitating long-term fate for an undetermined proportion of people who survive COVID …

To the Editor—We report the kinetics of immune responses in relation to clinical and
virological features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) …

To the Editor—As the COVID Human Genetic Effort consortium (https://www. covidhge.
com/), we have studied genetic and immunological determinants of life-threatening COVID …

Respiratory failure is the leading cause of death in patients with severe SARS-CoV-2
infection,, but the host response at the lung tissue level is poorly understood. Here we …

To the Editor—In December 2019, a novel coronavirus was isolated, after a cluster of
patients in China were diagnosed with pneumonia of unknown cause1. This new isolate …

To the Editor—For the first time in the history of medicine, the evolution of a virus can be
observed 'as it happens'. Throughout this, molecular tools of unprecedented accuracy are …

Abstract Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction,–
during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

To the Editor—Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the
resulting coronavirus disease 2019 (COVID-19) have stretched healthcare systems thin …

Recent studies have provided insights into the pathology of and immune response to COVID-
19 [1, 2, 3, 4, 5, 6, 7, 8]. However, a thorough investigation of the interplay between infected …